ITEOS THERAPEUTICS INC. - COMMON STOCK

iTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer

10 Jan 2022 07:00:02 By Nasdaq GlobeNewswire

iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference

03 Jan 2022 16:01:00 By Nasdaq GlobeNewswire

iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021

09 Dec 2021 16:01:00 By Nasdaq GlobeNewswire

iTeos Reports Third Quarter 2021 Financial Results and Provides Corporate Updates

10 Nov 2021 16:01:00 By Nasdaq GlobeNewswire

iTeos to Report Third Quarter 2021 Financial Results on November 10, 2021

03 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

iTeos Therapeutics to Participate in Upcoming September Investor Conferences

01 Sep 2021 07:00:00 By Nasdaq GlobeNewswire

iTeos Reports Second Quarter 2021 Financial Results and Provides Business Update

12 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

iTeos Therapeutics to Present at Wedbush PacGrow Healthcare Conference 2021

03 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

iTeos Therapeutics to Present at William Blair Biotech Focus Conference 2021

08 Jul 2021 10:03:50 By Nasdaq GlobeNewswire

iTeos Therapeutics and GSK announce development and commercialisation collaboration for EOS-448, an anti-TIGIT monoclonal antibody, enabling novel next-generation immuno-oncology combinations

14 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

iTeos Therapeutics Announces New Phase 1/2a Data Indicating Antitumor Activity of inupadenant, its Adenosine A2A Receptor Antagonist, at ASCO 2021

04 Jun 2021 09:00:00 By Nasdaq GlobeNewswire

iTeos Reports First Quarter 2021 Financial Results and Provides Business Update

13 May 2021 16:01:00 By Nasdaq GlobeNewswire

iTeos to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 13, 2021

06 May 2021 16:01:01 By Nasdaq GlobeNewswire

iTeos Appoints Tony Ho M.D. and Robert Iannone M.D., M.S.C.E., two Highly Accomplished R&D Executives to its Board of Directors

03 May 2021 16:01:00 By Nasdaq GlobeNewswire

iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021

10 Apr 2021 08:30:00 By Nasdaq GlobeNewswire

iTeos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

24 Mar 2021 16:45:00 By Nasdaq GlobeNewswire

iTeos to Present at Upcoming Investor Conferences in March

23 Feb 2021 07:00:01 By Nasdaq GlobeNewswire

iTeos to Present at the 10th Annual SVB Leerink Global Healthcare Conference

17 Feb 2021 07:00:00 By Nasdaq GlobeNewswire

iTeos to Present at the 39th Annual J.P. Morgan Healthcare Conference

05 Jan 2021 07:00:00 By Nasdaq GlobeNewswire